ATE412180T1 - Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten - Google Patents
Verfahren und mittel zum nachweis von durch gluten induzierten krankheitenInfo
- Publication number
- ATE412180T1 ATE412180T1 AT02718225T AT02718225T ATE412180T1 AT E412180 T1 ATE412180 T1 AT E412180T1 AT 02718225 T AT02718225 T AT 02718225T AT 02718225 T AT02718225 T AT 02718225T AT E412180 T1 ATE412180 T1 AT E412180T1
- Authority
- AT
- Austria
- Prior art keywords
- test
- induced diseases
- autoantigen
- liberated
- directed
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 210000004369 blood Anatomy 0.000 abstract 3
- 239000008280 blood Substances 0.000 abstract 3
- 208000015943 Coeliac disease Diseases 0.000 abstract 1
- 206010012468 Dermatitis herpetiformis Diseases 0.000 abstract 1
- 108010068370 Glutens Proteins 0.000 abstract 1
- 108700039882 Protein Glutamine gamma Glutamyltransferase 2 Proteins 0.000 abstract 1
- 102100038095 Protein-glutamine gamma-glutamyltransferase 2 Human genes 0.000 abstract 1
- 210000003743 erythrocyte Anatomy 0.000 abstract 1
- 235000021312 gluten Nutrition 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91045—Acyltransferases (2.3)
- G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
- G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
- G01N2800/202—Dermatitis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Rehabilitation Therapy (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20010868A FI20010868A0 (fi) | 2001-04-25 | 2001-04-25 | Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE412180T1 true ATE412180T1 (de) | 2008-11-15 |
Family
ID=8561063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02718225T ATE412180T1 (de) | 2001-04-25 | 2002-04-24 | Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7361480B2 (de) |
| EP (1) | EP1390753B1 (de) |
| AT (1) | ATE412180T1 (de) |
| BR (1) | BRPI0209172B8 (de) |
| CA (1) | CA2445102C (de) |
| DE (1) | DE60229513D1 (de) |
| ES (1) | ES2314043T3 (de) |
| FI (1) | FI20010868A0 (de) |
| HU (1) | HU229679B1 (de) |
| PL (1) | PL208039B1 (de) |
| WO (1) | WO2002086509A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20010868A0 (fi) * | 2001-04-25 | 2001-04-25 | Markku Maeki | Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi |
| GB0117870D0 (en) | 2001-07-21 | 2001-09-12 | Univ Nottingham Trent | Method of diagnosis and kit of parts therefor |
| GB0304993D0 (en) * | 2003-03-05 | 2003-04-09 | Univ Nottingham Trent | Novel screening method |
| FR2857453B1 (fr) * | 2003-07-11 | 2007-04-20 | Covalab | Procede de detection serologique de la maladie coeliaque et necessaire de diagnostic associe |
| WO2010060155A1 (en) | 2008-11-30 | 2010-06-03 | Nexpep Pty Ltd | Compositions and methods for treatment of celiac disease |
| CA2923822A1 (en) | 2013-09-10 | 2015-03-19 | Immusant, Inc. | Dosage of a gluten peptide composition |
| US10370718B2 (en) | 2014-09-29 | 2019-08-06 | Immusant, Inc. | Use of HLA genetic status to assess or select treatment of celiac disease |
| WO2025233646A2 (en) | 2024-05-09 | 2025-11-13 | Debreceni Egyetem | Detection of celiac disease-specific autoantibodies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE461616B (sv) * | 1987-05-08 | 1990-03-05 | Biocarb Ab | Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex |
| US5200344A (en) * | 1990-11-13 | 1993-04-06 | Blaser Martin J | Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens |
| WO1994020857A1 (en) * | 1993-03-11 | 1994-09-15 | The Regents Of The University Of California | Assay for humoral immunity to macromolecules |
| DE19630557C2 (de) * | 1996-07-18 | 1998-07-02 | Schuppan Detlef Priv Doz Dr Dr | Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie |
| AU776091B2 (en) * | 1999-06-28 | 2004-08-26 | Immundiagnostik Ag | Diagnosis of gluten sensitive enteropathy and other autoimmunopathies |
| US6703208B1 (en) * | 1999-10-20 | 2004-03-09 | Immco Diagnostics | Immunological assay for detection of antibodies in celiac disease |
| FI20010868A0 (fi) * | 2001-04-25 | 2001-04-25 | Markku Maeki | Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi |
-
2001
- 2001-04-25 FI FI20010868A patent/FI20010868A0/fi unknown
-
2002
- 2002-04-24 US US10/475,786 patent/US7361480B2/en not_active Expired - Lifetime
- 2002-04-24 AT AT02718225T patent/ATE412180T1/de not_active IP Right Cessation
- 2002-04-24 DE DE60229513T patent/DE60229513D1/de not_active Expired - Lifetime
- 2002-04-24 CA CA2445102A patent/CA2445102C/en not_active Expired - Fee Related
- 2002-04-24 HU HU0400066A patent/HU229679B1/hu unknown
- 2002-04-24 PL PL366996A patent/PL208039B1/pl unknown
- 2002-04-24 WO PCT/FI2002/000340 patent/WO2002086509A1/en not_active Ceased
- 2002-04-24 BR BRPI0209172A patent/BRPI0209172B8/pt not_active IP Right Cessation
- 2002-04-24 EP EP02718225A patent/EP1390753B1/de not_active Expired - Lifetime
- 2002-04-24 ES ES02718225T patent/ES2314043T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002086509A8 (en) | 2003-01-16 |
| WO2002086509A1 (en) | 2002-10-31 |
| BRPI0209172B1 (pt) | 2017-06-06 |
| US7361480B2 (en) | 2008-04-22 |
| CA2445102C (en) | 2012-01-03 |
| ES2314043T3 (es) | 2009-03-16 |
| PL366996A1 (en) | 2005-02-07 |
| HUP0400066A2 (hu) | 2004-04-28 |
| EP1390753B1 (de) | 2008-10-22 |
| CA2445102A1 (en) | 2002-10-31 |
| HU229679B1 (en) | 2014-04-28 |
| DE60229513D1 (de) | 2008-12-04 |
| US20040115750A1 (en) | 2004-06-17 |
| PL208039B1 (pl) | 2011-03-31 |
| BR0209172A (pt) | 2004-08-03 |
| BRPI0209172B8 (pt) | 2021-07-27 |
| FI20010868A0 (fi) | 2001-04-25 |
| EP1390753A2 (de) | 2004-02-25 |
| HUP0400066A3 (en) | 2006-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1421215T3 (da) | Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA | |
| DE60300339D1 (de) | Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben | |
| MX374971B (es) | Metodos y aparato para la deteccion de sensibilidad al gluten y su diferenciacion de la enfermedad celiaca | |
| ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
| ATE438853T1 (de) | Diagnostische testvorrichtung | |
| DK1734368T3 (da) | Annexin-autoantistoffer anvendt som markörer for lungecancer | |
| NO982265L (no) | Diagnostikk for og mediatorer for inflammatoriske forstyrrelser | |
| ATE370414T1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| WO2006036173A3 (en) | Frizzled proteins and detection and treatment of cancer | |
| ATE412180T1 (de) | Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten | |
| DE602006006855D1 (de) | Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb) | |
| DE60325382D1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
| WO2008060376A3 (en) | Algorithims for multivariant models to combine a panel of biomarkers for assessing the risk of developing ovarian cancer | |
| ATE427500T1 (de) | Hamoglobintest fur neonatales screening | |
| WO2007103211A3 (en) | Methods to identify fat and lean animals using class predictors | |
| ATE554388T1 (de) | Verfahren und immunabsorbentien zur spezifischen detektion und absorption zöliakie- und dermatitis herpetiformis assoziierter antikörper | |
| WO2004109286A3 (en) | Methods for detecting and treating cancer using podocalyxin and/or endoglycan | |
| DK0991945T3 (da) | Fremgangsmåde til identifikation af tumor-antigener med antistoffer i serum | |
| ATE420365T1 (de) | Präparierung von sphären für diagnostische tests | |
| ATE557277T1 (de) | Verfahren zur diagnose von endometriose mittels tfpi-2 protein | |
| DE602005023329D1 (de) | VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8 | |
| BRPI0607016A2 (pt) | marcadores polipeptìdicos para o diagnóstico de cáncer de próstata | |
| ATE192236T1 (de) | Menschliche phospholipase aktivierender proteinteil | |
| WO2022241292A3 (en) | Use of markers in the diagnosis and treatment of parkinson's disease | |
| WO2004016065A3 (es) | SISTEMA Y PROCEDIMIENTO INMUNOCROMATOGRÁFICO PARA LA INDENTIFICACIÓN SIMULTÁNEA DE ANTICUERPOS FRENTE A AGA Y t-TG, Y SU USO EN EL DIAGNOSTICO DE ENFERMEDAD CELIACA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties | ||
| REN | Ceased due to non-payment of the annual fee |